ArticleBreast (Edinburgh, Scotland)2026
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons.
Jingjing Xiao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.